Mensifem (Dry Extract From Cimicifuga Racemosa (L.) Nutt., Rhizoma (Black Cohosh) (5-10:1), Extraction Solvent)

The exact mechanism is not fully defined, but the extract is believed to act through weak estrogenic activity and modulation of serotonergic pathways. These actions may influence the hypothalamic thermoregulatory center, helping to reduce the frequency and severity of vasomotor symptoms associated with menopause.

The appropriate dose of Mensifem is determined by a qualified healthcare professional based on individual needs, age, and overall health status. Patients should follow the prescriber’s instructions and the product label; no universal dosing regimen is provided here.

Safety data for Mensifem in pregnancy and lactation are limited. It is generally advised to avoid use during pregnancy and to exercise caution while breastfeeding unless a healthcare provider determines that the potential benefits outweigh any possible risks.

To place an order, submit an enquiry on the Mensifem product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mensifem offers a botanical alternative to conventional hormone replacement therapy (HRT). While HRT provides direct estrogen supplementation, Mensifem’s extract has a milder, indirect estrogenic effect and may be preferred by individuals seeking a non‑synthetic option, though efficacy can vary between patients.

Mensifem should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, excessive heat, and direct sunlight to maintain its stability and potency throughout its shelf life.

Mensifem is taken orally, typically with water. The exact administration schedule—such as frequency and timing relative to meals—should follow the prescribing clinician’s guidance and the instructions on the product label.

Although uncommon, serious adverse events may include liver enzyme elevation, severe allergic reactions such as anaphylaxis, and rare thrombotic (blood clot) events. Patients should seek immediate medical attention if they experience signs of liver dysfunction, severe rash, swelling, or breathing difficulties.

Mensifem is not recommended for women who are pregnant, nursing without medical advice, have known hypersensitivity to Black Cohosh, or have hormone‑sensitive conditions such as certain breast or uterine cancers. Individuals on anticoagulant therapy or with significant liver disease should also consult a healthcare professional before use.